BioCentury
ARTICLE | Company News

Genesis, SPA merging eczema programs

November 20, 2001 8:00 AM UTC

Genesis R&D (ASX:GEN) and SR Pharma (LSE:SPA), which are both developing M. vaccae-based therapeutics for atopic dermatitis (eczema), plan to merge their programs and select 1 therapy for further deve...